Jerome Fischer is an Endocrinology/Metabolic physician affiliated with Diabetes & Glandular Disease Clinic. OpenAlex indexes 11 publications with 645 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5107 Medical Drive
San Antonio, TX 78229
Telephone
210-614-8612Provider last certified this registry record 9 Jun 2022.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20251 payment
- Dexcom, Inc.Program year20251 payment
- Dexcom, Inc.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
51.2%Insulin Analog28.3%Novolog Flexpen23%Humalog Kwikpen U-10016%Lantus Solostar13%Levemir Flextouch10%Toujeo Solostar10%Lantus7%Basaglar Kwikpen U-1006%Novolog6%Tresiba Flextouch U-1005%Humalog4%Part D≥57 patientsBiguanide (metformin)8.5%Metformin Hcl69%Metformin Hcl Er31%Part D≥76 patients+ 5 more classes in this area
Hormonal (systemic)
30.3%l-Thyroxine30.3%Levothyroxine Sodium74%Synthroid27%Part D≥202 patientsCardiovascular
16.9%Statin7.7%Atorvastatin Calcium56%Simvastatin19%Rosuvastatin Calcium14%Pravastatin Sodium11%Part D<11 patientsACE inhibitor2.9%Lisinopril52%Ramipril29%Lisinopril-Hydrochlorothiazide19%Part D<11 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Sensor-Augmented Insulin Pump Therapy: Results of the First Randomized Treat-to-Target Study
Diabetes Technology & Therapeutics
2008 - United States Patient Preference and Usability for the New Disposable Insulin Device Solostar® versus other Disposable Pens
Journal of Diabetes Science and Technology
2008 - Transfer of Transdermally Applied Testosterone to Clothing: A Comparison of a Testosterone Patch Versus a Testosterone Gel
The Journal of Sexual Medicine
2005
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”